Hypoglycemic Agents: all 3,927 studies that test it
Page 34 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Study of Pioglitazone in Patients With Amyotrophic Lateral SclerosisTerminatedNCT00690118Phase 2
- Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)CompletedNCT00688207Phase 1
- Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical DecayStatus unknownNCT00687466Phase 3
- Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular AxisCompletedNCT00683735Phase 2/3
- Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)Status unknownNCT00681733Not applicable
- Metformin in Gestational Diabetes MellitusCompletedNCT00681460Not applicable
- Metformin and Lifestyle Intervention in Women With Polycystic Ovary SyndromeCompletedNCT00679679Phase 4
- Risk Reduction in Coronary Heart DiseaseCompletedNCT00679237Not applicable
- Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNCT00676819Phase 4
- Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With InsulinCompletedNCT00676260Phase 2
- Physical Exercise Versus Rosiglitazone in CAD and PrediabetesCompletedNCT00675740Phase 4
- Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.CompletedNCT00672919Phase 4
- Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human InsulinStatus unknownNCT00668850Phase 3
- Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose ToleranceCompletedNCT00667498Phase 4
- Glufast On Insulin Glargine Trial in Type 2 DMCompletedNCT00663884Phase 4
- Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual CareWithdrawnNCT00663624Phase 4
- Early Diagnosis of Diabetes Mellitus in Patients With Cystic FibrosisCompletedNCT00662714Phase 3
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)CompletedNCT00659477Phase 4
- The Copenhagen Insulin and Metformin Therapy TrialCompletedNCT00657943Phase 4
- Pioglitazone Incretin StudyCompletedNCT00656864Phase 4
- Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)CompletedNCT00653341Phase 3
- Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)CompletedNCT00653302Phase 4
- Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy SubjectsCompletedNCT00651105Phase 3
- Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00650533Phase 1
- Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650312Phase 1
- Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650234Phase 1
- Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial InfarctionCompletedNCT00650143Phase 2/3
- Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mgCompletedNCT00649948Phase 1
- Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mgCompletedNCT00649558Phase 1
- Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mgCompletedNCT00649350Phase 1
- Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mgCompletedNCT00649012Phase 1
- Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mgCompletedNCT00648518Phase 1
- Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mgCompletedNCT00648492Phase 1
- Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00648362Phase 1
- Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)TerminatedNCT00647023Not applicable
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal InsufficiencyCompletedNCT00646542Phase 3
- Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)CompletedNCT00642915Phase 4
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)CompletedNCT00642798Phase 1
- Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2Status unknownNCT00638209Not applicable
- Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNCT00636766Not applicable
- Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 DiabetesTerminatedNCT00633997Phase 1/2
- Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of GlimepirideCompletedNCT00633425Phase 4
- Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT00633282Phase 2
- DZX Mediated Insulin Suppression in Obese MenCompletedNCT00631033Phase 2
- Beta-cell Function in Glucose Abnormalities and Acute Myocardial InfarctionCompletedNCT00627744Phase 4
- Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)TerminatedNCT00627471Phase 4
- Insulin Detemir Action in CerebroCompletedNCT00626080Not applicable
- Treatment of Impaired Glucose Tolerance in PregnancyCompletedNCT00625781Not applicable
- A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic PatientsCompletedNCT00624767Phase 2
- Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCompletedNCT00624364Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal InsufficiencyCompletedNCT00616811Phase 3
- Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral AneurysmsWithdrawnNCT00615381Not applicable
- Effect of GSK376501 on CYP450 Activity in Healthy Adult SubjectsCompletedNCT00615212Phase 1
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCompletedNCT00612599Phase 3
- Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes MellitusCompletedNCT00610038Phase 2
- The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning DosingCompletedNCT00609895Phase 4
- Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 DiabetesCompletedNCT00609856Phase 4
- Glimepiride Induced Insulin Secretion Will be Inhibited by HypoglycemiaCompletedNCT00608179Not applicable
- Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With DiabetesCompletedNCT00607737Phase 4
- Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT00605111Phase 4
- Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
- Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesCompletedNCT00604656Phase 3
- Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat AsthmaWithdrawnNCT00604578Phase 2
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
- Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCompletedNCT00604344Phase 3
- Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
- Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT00600366Phase 4
- Preventing Epilepsy After Traumatic Brain Injury With TopiramateTerminatedNCT00598923Early Phase 1
- Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
- Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without DiabetesCompletedNCT00598013Not applicable
- Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCompletedNCT00597233Phase 4
- Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
- Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
- Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4
- Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
- Genetic Variation in OCT1 and Response to MetforminWithdrawnNCT00588172Phase 4
- Sulodexide Treatment in Patients With Dense Deposit DiseaseWithdrawnNCT00583427Phase 1
- Extension to Study HMR1964A/3011 in BelgiumCompletedNCT00576862Phase 4
- Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With InsulinCompletedNCT00576784Phase 4
- An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical PracticeCompletedNCT00576368Phase 4
- Initiation of Insulin Aspart in Type 2 DiabetesCompletedNCT00572806Phase 4
- Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired PatientsCompletedNCT00572650Phase 1
- Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesCompletedNCT00571935Phase 4
- Effect of Thiazolidinedione Treatment Vascular Risk MarkersCompletedNCT00571506Phase 4
- The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress DisorderWithdrawnNCT00571246Phase 3
- Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced CirrhosisCompletedNCT00570622Phase 4
- Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive DisorderCompletedNCT00570050Phase 3
- Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCompletedNCT00569400Phase 3
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
- Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
- Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCompletedNCT00567775Phase 2
- Pharmacokinetic Study of Vildagliptin in Patients With Renal ImpairmentCompletedNCT00567047Phase 1
- Basal Insulins - PharmacodynamicsCompletedNCT00566124Phase 4
- Insulin Glargine, INITIATE Metabolic and Economic Outcomes of LantusCompletedNCT00565162Phase 4
- Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCompletedNCT00564668Phase 3